Health & Environmental Research Online (HERO)


Print Feedback Export to File
2718067 
Journal Article 
Amniotic fluid phthalate levels and male fetal gonad function 
Jensen, MS; Anand-Ivell, R; Nørgaard-Pedersen, B; Jönsson, BA; Bonde, JP; Hougaard, DM; Cohen, A; Lindh, CH; Ivell, R; Toft, G 
2015 
Yes 
Epidemiology
ISSN: 1044-3983
EISSN: 1531-5487 
LIPPINCOTT WILLIAMS & WILKINS 
PHILADELPHIA 
26 
91-99 
English 
BACKGROUND: Prenatal exposure to phthalates may pose a threat to human male reproduction. However, additional knowledge about the in vivo effect in humans is needed, and reported associations with genital abnormalities are inconclusive. We aimed to study prenatal di(2-ethylhexyl) phthalate (DEHP) and diisononyl phthalate (DiNP) exposure in relation to cryptorchidism, hypospadias, and human fetal Leydig cell function.

METHODS: We studied 270 cryptorchidism cases, 75 hypospadias cases, and 300 controls. Second-trimester amniotic fluid samples were available from a Danish pregnancy-screening biobank (n = 25,105) covering 1980-1996. We assayed metabolites of DEHP and DiNP (n = 645) and steroid hormones (n = 545) by mass spectrometry. We assayed insulin-like factor 3 by immunoassay (n = 475) and analyzed data using linear or logistic regression.

RESULTS: Mono(2-ethyl-5-carboxypentyl) phthalate (5cx-MEPP, DEHP metabolite) was not consistently associated with cryptorchidism or hypospadias. However, we observed an 18% higher (95% confidence interval [CI] = 5%-33%) testosterone level, and a 41% lower (-56% to -21%) insulin-like factor 3 level in the highest 5cx-MEPP tertile compared with the lowest. Mono(4-methyl-7-carboxyheptyl) phthalate (7cx-MMeHP, DiNP metabolite) showed elevated odds ratio point estimates for having cryptorchidism (odds ratio = 1.28 [95% CI = 0.80 to 2.01]) and hypospadias (1.69 [0.78 to 3.67]), but was not consistently associated with the steroid hormones or insulin-like factor 3.

CONCLUSIONS: Data on the DEHP metabolite indicate possible interference with human male fetal gonadal function. Considering the DiNP metabolite, we cannot exclude (nor statistically confirm) an association with hypospadias and, less strongly, with cryptorchidism. 
Adult; Amniotic Fluid/chemistry; Case-Control Studies; Cryptorchidism/epidemiology; Denmark/epidemiology; Diethylhexyl Phthalate/analysis; Environmental Exposure/statistics & numerical data; Gonadal Steroid Hormones/analysis; Hydrocortisone/analysis; Hypospadias/epidemiology; Immunoassay; Infant, Newborn; Insulin/analysis; Leydig Cells; Linear Models; Logistic Models; Mass Spectrometry; Phthalic Acids/analysis; Pregnancy; Proteins/analysis; 4010KIX4CK; C42K0PH13C; WI4X0X7BPJ 
IRIS
• Dibutyl Phthalate (DBP)
     Database Searches
          Litsearch March 2015 - June 2015
               WOS
          LitSearch Jul 2016 - Jan 2017
               Prior search overlap
               WoS
     Excluded: No Primary Data on Health Effects
          Not chemical specific
     Studies with Health Effects Data
          Human health effects studies
     Litsearch June 2015 - Jan 2016
          Web of Science
• Diisononyl Phthalate (DINP)
     Literature Search
     Studies with Health Effects Data
          Human health effects studies
• Phthalates – Targeted Search for Epidemiological Studies
     Source – all searches
          Pubmed
          WOS
     Included
          DEHP
          DiNP
     Source – Dec 2014 Update (Private)
          Pubmed
     Source – Mar 2015 Update (Private)
          Pubmed
          WOS
     Source – Dec 2015 Update (Private)
          Pubmed
          WOS
     Source - Jun 2016 Update (Private)
          WOS